Research & IP · South Korea

ToolGen

Korean genome-editing firm (KOSDAQ-listed) holding one of the contested foundational CRISPR-Cas9 patent families.

Headquarters
Seoul, South Korea · East Asia
Value chain
Research & IP(Research & design)
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
1999
Ownership
Listed
Listing
KRX:199800 on Google Finance
Website
toolgen.com
Relevance
Low at its strongest, in Synthetic Biology & Genetic Engineering

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Research · listed #25 of 50

    Korean genome-editing firm (KOSDAQ-listed) holding one of the contested foundational CRISPR-Cas9 patent families.

    Relevance: Korean genome-editing firm with contested CRISPR IP

    Source · en.wikipedia.org